Phosphatase Inhibitors

Overview

Phosphatase inhibitors are a new class of chemical compounds that have shown promising results in the field of chemistry. These inhibitors are designed to interact with enzymes in the body that regulate cellular processes by removing phosphate groups from proteins. By targeting these enzymes, phosphatase inhibitors can influence a wide range of cellular functions, including cell growth, differentiation, and signal transduction. Recent studies have shown that phosphatase inhibitors have potential therapeutic applications in a variety of diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. In cancer therapy, phosphatase inhibitors can potentially increase the efficacy of chemotherapy by preventing cancer cells from repairing DNA damage caused by chemotherapy drugs. They can also interfere with the growth and migration of cancer cells, making them a promising target for future cancer treatments. In the field of autoimmune disorders, phosphatase inhibitors have shown potential in treating conditions such as rheumatoid arthritis and lupus. These inhibitors can target the immune system, preventing it from attacking healthy tissues in the body. They can also regulate the activity of inflammatory cytokines, which play a significant role in autoimmune diseases. In neurodegenerative diseases such as Alzheimer's and Parkinson's, phosphatase inhibitors have shown promise by preventing the accumulation of toxic proteins in the brain. They can also enhance neuronal function, improving cognitive function in patients with dementia. In conclusion, phosphatase inhibitors are a promising class of compounds that have the potential to revolutionize the field of medicine. Their ability to regulate a wide range of cellular functions makes them a promising target for the development of new treatments for a variety of diseases.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 2 articles above have been cited 8 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Skeletal muscle transcriptome in healthy aging
  2021 · Nature Communications
• New insight into the role of MMP14 in metabolic balance
  2016 · PeerJ
• RETRACTED: N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions
  2014 · The Journal of Neuroscience
• Discovery and Quantification in Mass Spectrometry-based Proteomics
  C. Ruse et al. · 2014 ·
• The ubiquitin conjugating enzyme UBE2L3 regulates TNFα-induced linear ubiquitination
  2014 · Cell Research
• The ubiquitin conjugating enzyme UBE2L3 regulates TNFα-induced linear ubiquitination
  2013 · Cell Research
• Proteomics Defines Protein Interaction Network of Signaling Pathways
  Shitao Li · 2012 · Bioinformatics of Human Proteomics
• Proteomics Defines Protein Interaction Network of Signaling Pathways
  2012 · Translational bioinformatics

A sample of recent works citing this journal's research on Phosphatase Inhibitors, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics